老年急性冠脉综合征的管理
本文综述老年急性冠脉综合征(ACS)患者的循证介入与药物治疗数据。总体上,侵入性策略在ACS全谱中较保守策略显示更好的获益-风险比;而更强的抗栓二级预防策略与出血事件增加相关且未降低死亡率。建议结合老年综合评估进行多学科评估以实现整体管理。
要点
- 老年ACS患者中侵入性策略较保守策略显示更好的获益-风险比
- 更强效抗栓二级预防策略增加出血且未降低死亡率
- 应结合老年综合评估进行多学科团队评估以优化治疗
核心结论
- 在老年ACS患者中,侵入性策略在ACS全谱中较保守策略显示更好的获益-风险比,即使考虑临床复杂性和多重共病。
- 更强效的抗栓二级预防策略与出血事件增加相关,且未显示死亡率获益。
- 应始终考虑结合老年评估的多学科评估,以实现整体管理并根据生物学脆弱性优化治疗。
研究设计与样本
- 综述,聚焦老年ACS患者循证介入与药物治疗的现有数据,包括指南指导的管理。
主要发现
- 老年患者在前瞻性研究和随机临床试验中代表性不足。
- 过去十年中在该人群开展了少数特定试验,使管理更具循证依据。
- 老年人群异质、复杂且高危,管理需超越冠脉解剖变量的多维临床方法。
临床怎么用
- 对老年ACS患者应考虑侵入性策略而非保守策略。
- 避免盲目采用更强效抗栓二级预防策略,需权衡出血风险。
- 引入老年综合评估和多学科团队以个体化优化治疗。
局限性
- 老年患者在前瞻性研究和随机临床试验中代表性不足。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Older patients are underrepresented in prospective studies and randomized clinical trials of acute coronary syndromes (ACS). Over the last decade, a few specific trials have been conducted in this population, allowing more evidence-based management. Older adults are a heterogeneous, complex, and high-risk group whose management requires a multidimensional clinical approach beyond coronary anatomic variables. This review focuses on available data informing evidence-based interventional and pharmacological approaches for older adults with ACS, including guideline-directed management. Overall, an invasive approach appears to demonstrate a better benefit-risk ratio compared to a conservative one across the ACS spectrum, even considering patients' clinical complexity and multiple comorbidities. Conversely, more powerful strategies of antithrombotic therapy for secondary prevention have been associated with increased bleeding events and no benefit in terms of mortality reduction. An interdisciplinary evaluation with geriatric assessment should always be considered to achieve a holistic approach and optimize any treatment on the basis of the underlying biological vulnerability.
引用
- Morici N, De Servi S, De Luca L, et al. Management of acute coronary syndromes in older adults. Eur Heart J. 2022. PMID: 34347065. doi:10.1093/eurheartj/ehab391
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。